Cascade Responsive Photosensitizer for Precise Delivery and Photodynamic Therapy
We report a tumor microenvironment-responsive photosensitizer (<b>1</b>) as a molecular chameleon with cascade transformation capabilities for precision-controlled photosensitizer delivery. <b>1</b> is encapsulated in a pH-responsive surfactant to form <b>1a</b> with a PEGylated surface that does not generate ROS in normal tissues. The ROS generation is activated by the overexpressed glutathione at the acidic tumor site to yield <b>2</b> through an aromatic nucleophilic substitution. This transformation of hydrophobic <b>1</b> to hydrophilic <b>2</b> leads to the release of photosensitizer with size reduction, potentially enhancing drug accumulation and facilitating tumor penetration. Furthermore, after treatment, <b>2</b> is deactivated by γ-glutamyl transferase through specific hydrolysis and intramolecular rearrangement reactions, thereby reducing the potential undesired phototoxicity. In vitro and in vivo studies show that is deactivated by γ-glutamyl transferase through specific hydrolysis and intramolecular rearrangement reactions, thereby reducing the potential undesired phototoxicity. In vitro and in vivo studies show that <b>1a</b> affords excellent phototoxicity to cancer cells by the pyroptosis pathway. This work offers a promising strategy to design molecular chameleons to control spatiotemporal delivery of photosensitizes and to enhance the photodynamic therapy efficacy.
Authors
- Kun‐Xu Teng (ORCID: https://orcid.org/0000-0002-9391-9889)
- Li‐Ya Niu (ORCID: https://orcid.org/0000-0002-5376-6902)
- Qing‐Zheng Yang (ORCID: https://orcid.org/0000-0002-9131-4907)
- Dongsheng Zhang (ORCID: https://orcid.org/0000-0003-2007-8377)
- Na Shao (ORCID: https://orcid.org/0000-0003-1163-5856)
Institutions
- Beijing Normal University (CN)
- Henan Normal University (CN)
Publication Details
- Journal
- Journal of Medicinal Chemistry
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1021/acs.jmedchem.5c00316
- Citations
- 5
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 3.37
Funders
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
- National Postdoctoral Program for Innovative Talents